J Korean Med Sci.  2010 Jun;25(6):813-816. 10.3346/jkms.2010.25.6.813.

Human Cord Blood Stem Cell Therapy for Treatment of Stress Urinary Incontinence

• Lee CN
• Jang JB
• Kim JY
• Koh C
• Baek JY
• Lee KJ

• KMID: 2150856
• DOI: http://doi.org/10.3346/jkms.2010.25.6.813

Abstract

Our objective in this study was to evaluate the safety and efficacy of transurethral cord blood stem cell injection for treatment of stress urinary incontinence in women. Between July 2005 and July 2006, 39 women underwent transurethral umbilical cord blood stem cell injection performed by one operator at a single hospital. All patients had stress urinary incontinence. The patients were evaluated 1, 3, and 12 months postoperatively. No postoperative complications were observed. 28 patients (77.8%) were more than 50% satisfied according to the Patient's Satisfaction results after 1 month, 29 patients (83%) were more than 50% satisfied according to the Patient's Satisfaction results after 3 months, and 26 (72.2%) continuously showed more than 50% improvement after 12 months. Intrinsic sphincter deficiency and mixed stress incontinency improved in the ten patients evaluated by urodynamic study. Our results suggest that transurethral umbilical cord blood stem cell injection is an effective treatment for women with all types of stress urinary incontinence.

Keyword

Urinary Incontinence, Stress; Intrinsic Sphincter Deficiency; Umbilical Cord Blood Stem Cell; Urodynamic Study

Reference

1. Norton P, Brubaker L. Urinary incontinence in women. Lancet. 2006. 367:57–67.

2. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol. 2000. 53:1150–1157.

3. Yiou R, Lefaucheur JP, Atala A. The regeneration process of the striated urethral sphincter involves activation of intrinsic satellite cells. Anat Embryol (Berl). 2003. 206:429–435.

4. Yokoyama T, Yoshimura N, Dhir R, Qu Z, Fraser MO, Kumon H, de Groat WC, Huard J, Chancellor MB. Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol. 2001. 165:271–276.

5. Cannon TW, Lee JY, Somogyi G, Pruchnic R, Smith CP, Huard J, Chancellor MB. Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology. 2003. 62:958–963.

6. Strasser H, Marksteiner R, Margreiter E, Pinggera GM, Mitterberger M, Fritsch H, Klima G, Radler C, Stadlbauer KH, Fussenegger M, Hering S, Bartsch G. Stem cell therapy for urinary incontinence. Urologe A. 2004. 43:1237–1241.

7. Fulle S, Protasi F, Di Tano G, Pietrangelo T, Beltramin A, Boncompagni S, Vecchiet L, Fano G. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol. 2004. 39:17–24.

8. Renault V, Thornell LE, Eriksson PO, Butler-Browne G, Mouly V. Regenerative potential of human skeletal muscle during aging. Aging Cell. 2002. 1:132–139.

9. Thornell LE, Lindstrom M, Renault V, Mouly V, Butler-Browne GS. Satellite cells and training in the elderly. Scand J Med Sci Sports. 2003. 13:48–55.

10. Jejurikar SS, Kuzon WM Jr. Satellite cell depletion in degenerative skeletal muscle. Apoptosis. 2003. 8:573–578.

11. Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med. 1989. 321:1174–1178.

12. Dasari VR, Spomar DG, Li L, Gujrati M, Rao JS, Dinh DH. Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury. Neurochem Res. 2008. 33:134–149.

13. Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg CD, Sanberg PR, Willing AE. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke. 2004. 35:2390–2395.

14. Lee HH, Kim HG, Jang SK, Choi OH. Cord blood-derived CD34 (+) cells promotes functional recovery in transient middle cerebral artery occlusion model of rat. Korean J Obstet Gynecol. 2007. 50:1521–1531.